Serum nitric oxide metabolites in subjects with metabolic syndrome

被引：78

作者：

Asl, Saleh Zahedi ^{[1
]}

Ghasemi, Asghar ^{[1
]}

Azizi, Fereidoun ^{[1
]}

机构：

[1] Shahid Beheshti Univ MC, Res Inst Endocrine Sci, Endocrine Res Ctr, Endocrine Physiol Lab, Tehran, Iran

来源：

CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 16-17期

关键词：

Metabolic syndrome; Nitric oxide; Type 2 diabetes mellitus;

D O I：

10.1016/j.clinbiochem.2008.08.076

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Objectives: Evidence are available showing that higher nitric oxide production is associated with metabolic disorders. The aim of this study was to determine serum nitric oxide metabolites (NOx) concentration in subjects with metabolic syndrome (MetS). Design and methods: In a cross-sectional study, NOx was measured in 3505 subjects, aged 20-94 years, using the Griess reaction. After excluding subjects taking medications for hypertension and dyslipidemia, data for 3 148 subjects were analyzed. Results: There was a direct association between the numbers of metabolic risk factors and serum NO, values in both genders (P for trend<0.05). After multivariable adjustment, serum NO, concentration was significantly higher in subjects with MetS [(31.9 (29.4-34.6) vs. 29.8 (27.6-32.1), p<0.01) or type 2 diabetes (34.6 (31.3-38.2) vs. 30.2 (27.9-32.6), p<0.001) as compared to their corresponding controls. Conclusions: Higher NO, concentrations in subjects with MetS and type 2 diabetes support the existing hypothesis that NO overproduction affects insulin's metabolic actions. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：1342 / 1347

页数：6

共 34 条

[1]

[Anonymous], CAN J DIABETES

[2] Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1) [J].

Azizi, F ;

Rahmani, M ;

Emami, H ;

Mirmiran, P ;

Hajipour, R ;

Madjid, M ;

Ghanbili, J ;

Ghanbarian, A ;

Mehrabi, Y ;

Saadat, N ;

Salehi, R ;

Mortazavi, N ;

Heydarian, P ;

Sarbazi, N ;

Allahverdian, S ;

Saadati, N ;

Ainy, E ;

Moeini, S .

SOZIAL-UND PRAVENTIVMEDIZIN, 2002, 47 (06) :408-426

[3] Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits [J].

Behr-Roussel, D ;

Rupin, A ;

Simonet, S ;

Bonhomme, E ;

Coumailleau, S ;

Cordi, A ;

Serkiz, B ;

Fabiani, JN ;

Verbeuren, TJ .

CIRCULATION, 2000, 102 (09) :1033-1038

[4] Methods to detect nitric oxide and its metabolites in biological samples [J].

Bryan, Nathan S. ;

Grisham, Matthew B. .

FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (05) :645-657

[5] Increased plasma concentration of nitric oxide in type 2 diabetes but not in nondiabetic individuals with insulin resistance [J].

Chien, WY ;

Yang, KD ;

Eng, HL ;

Hu, YH ;

Lee, PY ;

Wang, ST ;

Wang, PW .

DIABETES & METABOLISM, 2005, 31 (01) :63-68

[6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[7] The dual personality of NO [J].

Colasanti, M ;

Suzuki, H .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (07) :249-252

[8] Metabolic syndrome and urinary cGMP excretion in general population [J].

Cui, Renzhe ;

Iso, Hiroyasu ;

Pi, Jingbo ;

Kumagai, Yoshito ;

Yamagishi, Kazumasa ;

Tanigawa, Takeshi ;

Shimamoto, Takashi .

ATHEROSCLEROSIS, 2007, 190 (02) :423-428

[9] Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression [J].

Ding, YX ;

Vaziri, ND ;

Coulson, R ;

Kamanna, VS ;

Roh, DD .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 279 (01) :E11-E17

[10] The regulation and pharmacology of endothelial nitric oxide synthase [J].

Dudzinski, DM ;

Igarashi, J ;

Greif, D ;

Michel, T .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :235-276

← 1 2 3 4 →